109 related articles for article (PubMed ID: 38734797)
1. Study of original B cells producing pathogenic IgG and IgA autoantibodies in anti-BP180-type mucous membrane pemphigoid.
Hayashi D; Hashimoto T; Mine M; Ishii N; Hashimoto K; Tsuchisaka A; Tsuruta D
Arch Dermatol Res; 2024 May; 316(5):169. PubMed ID: 38734797
[No Abstract] [Full Text] [Related]
2. Mucous membrane pemphigoid with generalized blisters: IgA and IgG autoantibodies target both laminin-332 and type XVII collagen.
Hayashi I; Shinkuma S; Shimizu S; Natsuga K; Ujiie H; Yasui C; Tsuchiya K; Nishie W; Shimizu H
Br J Dermatol; 2012 May; 166(5):1116-20. PubMed ID: 22182184
[TBL] [Abstract][Full Text] [Related]
3. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180.
Schmidt E; Skrobek C; Kromminga A; Hashimoto T; Messer G; Bröcker EB; Yancey KB; Zillikens D
Br J Dermatol; 2001 Nov; 145(5):778-83. PubMed ID: 11736901
[TBL] [Abstract][Full Text] [Related]
4. Mucous membrane pemphigoid with IgG autoantibodies to the 120-kDa ectodomain of type XVII collagen (BP180/linear IgA dermatosis antigen) in a patient with idiopathic thrombocytopenic purpura.
Hirakawa Y; Oiso N; Ishii N; Koga H; Tatebayashi M; Uchida S; Matsuda H; Hashimoto T; Kawada A
Acta Derm Venereol; 2015 Apr; 95(4):493-4. PubMed ID: 25178495
[No Abstract] [Full Text] [Related]
5. Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180.
Choi Y; Lee SE; Fukuda S; Hashimoto T; Kim SC
J Dermatol; 2011 Feb; 38(2):169-72. PubMed ID: 21269314
[TBL] [Abstract][Full Text] [Related]
6. [Mucous membrane pemphigoid: IgG and IgA antibodies against the BP180 antigen].
España A; del Olmo J; Marquina M; Sitaru C
Actas Dermosifiliogr; 2005; 96(6):365-70. PubMed ID: 16476255
[TBL] [Abstract][Full Text] [Related]
7. Pure ocular mucous membrane pemphigoid reactive with both β4 integrin and the BP180 C-terminal domain.
Solano-López G; Concha-Garzón MJ; Sánchez-Pérez J; Hirako Y; Li X; Ishii N; Hashimoto T; Daudén E
Br J Dermatol; 2015 Feb; 172(2):542-4. PubMed ID: 25059542
[No Abstract] [Full Text] [Related]
8. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
[TBL] [Abstract][Full Text] [Related]
9. A Case of Anti-BP180-type Mucous Membrane Pemphigoid with IgG and IgA Autoantibodies Showing Distinct Reactivities.
Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Nakazawa M; Sawamura D
Acta Dermatovenerol Croat; 2022 Jul; 30(1):54-56. PubMed ID: 36153720
[TBL] [Abstract][Full Text] [Related]
10. Coexistence of pemphigus herpetiformis with IgG antibodies to desmocollin 1 and pemphigoid with IgG antibodies to BP180 C-terminal domain and laminin γ2.
Ohata C; Higashi Y; Yamagami J; Koga H; Ishii N; Kanekura T; Furumura M; Hashimoto T
JAMA Dermatol; 2013 Apr; 149(4):502-4. PubMed ID: 23715433
[No Abstract] [Full Text] [Related]
11. Clinical and Immunological Studies of 332 Japanese Patients Tentatively Diagnosed as Anti-BP180-type Mucous Membrane Pemphigoid: A Novel BP180 C-terminal Domain Enzyme-linked Immunosorbent Assay.
Yasukochi A; Teye K; Ishii N; Hashimoto T
Acta Derm Venereol; 2016 Aug; 96(6):762-7. PubMed ID: 26984589
[TBL] [Abstract][Full Text] [Related]
12. Detection of mucous membrane pemphigoid autoantibodies by full-length BP180 enzyme-linked immunosorbent assay.
Izumi K; Nishie W; Mai Y; Ujiie H; Iwata H; Natsuga K; Shimizu H
J Dermatol Sci; 2017 Nov; 88(2):247-248. PubMed ID: 28736219
[No Abstract] [Full Text] [Related]
13. The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis.
Roh JY; Yee C; Lazarova Z; Hall RP; Yancey KB
Br J Dermatol; 2000 Jul; 143(1):104-11. PubMed ID: 10886143
[TBL] [Abstract][Full Text] [Related]
14. Brunsting-Perry cicatricial pemphigoid associated with autoantibodies to the C-terminal domain of BP180.
Daito J; Katoh N; Asai J; Ueda E; Takenaka H; Ishii N; Hashimoto T; Kishimoto S
Br J Dermatol; 2008 Sep; 159(4):984-6. PubMed ID: 18637895
[No Abstract] [Full Text] [Related]
15. Anti-BP180-type oral mucous membrane pemphigoid reactive to both NC16a and C-terminal domains.
Uchiyama M; Mitsuhashi Y; Tsuboi R; Ishii N; Hayakawa T; Yasukochi A; Hashimoto T
Indian J Dermatol Venereol Leprol; 2015; 81(6):637-9. PubMed ID: 26515855
[No Abstract] [Full Text] [Related]
16. Brunsting-Perry-type cicatricial pemphigoid with IgG autoantibodies to LAD-1.
García-Martín P; Fraga J; Hashimoto T; García-Diez A
Br J Dermatol; 2014 Mar; 170(3):743-5. PubMed ID: 24124894
[No Abstract] [Full Text] [Related]
17. Native collagen XVII complex ELISA: An approach for diagnosis and monitoring of anti-integrin β4 mucous membrane pemphigoid.
Mai S; Izumi K; Itamoto S; Kurosawa S; Nagata Y; Hikichi S; Miyazawa H; Tokuchi K; Imafuku K; Yanagi T; Tsutsui M; Ujiie H
J Eur Acad Dermatol Venereol; 2024 May; 38(5):e385-e387. PubMed ID: 37908157
[No Abstract] [Full Text] [Related]
18. Concurrent mucous membrane pemphigoid and membranous glomerulonephritis in a patient with autoantibodies targeting the 1080 region of collagen XVII.
Stump M; Messingham KN; Fairley JA
Br J Dermatol; 2019 Oct; 181(4):835-836. PubMed ID: 30916378
[No Abstract] [Full Text] [Related]
19. IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis.
Christophoridis S; Büdinger L; Borradori L; Hunziker T; Merk HF; Hertl M
Br J Dermatol; 2000 Aug; 143(2):349-55. PubMed ID: 10951144
[TBL] [Abstract][Full Text] [Related]
20. Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid.
Murakami H; Nishioka S; Setterfield J; Bhogal BS; Black MM; Zillikens D; Yancey KB; Balding SD; Giudice GJ; Diaz LA; Nishikawa T; Kiyokawa C; Hashimoto T
J Dermatol Sci; 1998 May; 17(1):39-44. PubMed ID: 9651827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]